Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Regulation of Drug Resistance Via the Overexpression of Phopho-RKIP (P-RKIP) in Multiple Myeloma: Dephosphorylation of P-RKIP Reverses Drug Resistance

Devasis Chatterjee, Ph. D, Stavroula Baritaki, PhD, Benjamin Bonavida, PhD

Blood (2017) 130 (Supplement 1): 4971.

https://doi.org/10.1182/blood.V130.Suppl_1.4971.4971

Published: 2017

Journal Articles

High Expression of the Resistant Factor YY1 and Low Expression of the RKIP Chemosensitizing Factor in Multiple Myeloma: Delineation of Several Crosstalk Pathways That Regulate the Expression of These Factors

Stephanie Wottrich, Bachelor of Science, Samantha Kaufhold, Bachelor of Science, Stavroula Baritaki, PhD, Benjamin Bonavida, PhD

Blood (2017) 130 (Supplement 1): 5417.

https://doi.org/10.1182/blood.V130.Suppl_1.5417.5417

Published: 2017

Journal Articles

Targeting the Over-Expressed Transcription Factor Yin-Yang 1 (YY1) Sensitizes Resistant Multiple Myeloma (MM) Cell Lines to Apoptosis by Bortezomib or Melphalan,

Hong Liu, Sara Huerta-Yepez, Ph.D, Clara M. Rivera-Pazos, MD, Ma de Lourdes Cabera-Muñoz, MD, Stavroula Baritaki, Ph.D, Suzie Vardanyan, Manuel L Penichet, M.D., Ph.D., Haiming Chen, James R. Berenson, MD, Benjamin Bonavida, Ph.D

Blood (2011) 118 (21): 3991.

https://doi.org/10.1182/blood.V118.21.3991.3991

Published: 2011

Journal Articles

The Overexpression of Inactive Phosphorylated Raf-1 Kinase Inhibitory Protein (RKIP) in Multiple Myeloma (MM) Regulates the Resistance to Bortezomib-Induced Cytotoxicity: Reversal of Resistance by the PKC Inhibitor Bisindolylmalemide

Sara Huerta-Yepez, PhD, Stavroula Baritaki, PhD, Hong Liu, Karla MC Mendez-Maldonado, B.S., Manuel L Penichet, M.D., Ph.D., Mario I Vega, PhD, Otoniel Martinez-Maza, PhD, Haiming Chen, James R. Berenson, MD, Devasis Chatterjee, PhD, Benjamin Bonavida, Ph.D

Blood (2011) 118 (21): 2892.

https://doi.org/10.1182/blood.V118.21.2892.2892

Published: 2011

Journal Articles

Rituximab Inhibits the PI3K/Akt Survival Pathway In B-NHL Cells Via Induction of the PTEN Tumor Suppressor: Pivotal Roles of the Inhibition of the PTEN Repressors Snail and YY1

Stavroula Baritaki, PhD, Eriko Suzuki, Ph.D, Mario I. Vega, PhD, Haiming Chen, MD, PhD, James R. Berenson, MD, Benjamin Bonavida, PhD

Blood (2010) 116 (21): 3152.

https://doi.org/10.1182/blood.V116.21.3152.3152

Published: 2010

Journal Articles

An ADCC-Independent Mechanism of Rituximab-Mediated B-NHL Cells Depletion Via Sensitization to Cell Death through the Expression of TRAIL on NK Cells

Mario I. Vega, PhD, Sara Huerta-Yepez, PhD, Melisa Martinez-Paniagua, BSc, MSc, Stavroula Baritaki, PhD, Benjamin Bonavida, PhD

Blood (2010) 116 (21): 4919.

https://doi.org/10.1182/blood.V116.21.4919.4919

Published: 2010

Journal Articles

Reversal of Drug/TRAIL-Resistant B-NHL Cells to Apoptosis by the Combination of Rituximab (anti-CD20) and Either Mapatumumab or Lexatumumab

Mario I. Vega, PhD, Sara Huerta-Yepez, PhD, Melisa Martinez-Paniagua, BSc, MSc, Stavroula Baritaki, PhD, Haiming Chen, MD, PhD, James R. Berenson, MD, Benjamin Bonavida, PhD

Blood (2010) 116 (21): 4931.

https://doi.org/10.1182/blood.V116.21.4931.4931

Published: 2010

Journal Articles

Photodynamic Therapy (PDT)-Mediated Inhibition of the Transcription Factor Yin Yang 1 (YY1) That Regulates Resistance In Lymphoma

Valentina Rapozzi, Ph.D, Sara Huerta-Yepez, PhD, Abhijeet Joshi, Mario I. Vega, PhD, Stavroula Baritaki, PhD, Luigi E. Xodo, Ph.D, Benjamin Bonavida, PhD

Blood (2010) 116 (21): 5113.

https://doi.org/10.1182/blood.V116.21.5113.5113

Published: 2010

Journal Articles

Inhibition of the RKIP and PTEN-Transcription Repressor Snail in B-NHL by the Proteasome Inhibitor NPI-0052: Roles of RKIP and PTEN Induction in the Reversal of Resistance to TRAIL Apoptosis.

Stavroula Baritaki, Kam Yeung, Ph.D., Katherine Wu, Haiming Chen, MD, PhD, James R. Berenson, MD, Michael A. Palladino, PhD, Benjamin Bonavida, PhD

Blood (2009) 114 (22): 3938.

https://doi.org/10.1182/blood.V114.22.3938.3938

Published: 2009

Journal Articles

The Anti-CD 20 Mab R603 Induces PTEN and RKIP Expression in B-NHL Cells: Role in Inhibition of Constitutively Activated Akt and NF-ΚB Survival Anti-Apoptotic Pathways.

Loredana Militello, Stavroula Baritaki, Eriko Suzuki, Mario I. Vega, PhD, Margarita Salcedo, Benjamin Bonavida, PhD

Blood (2009) 114 (22): 1970.

https://doi.org/10.1182/blood.V114.22.1970.1970

Published: 2009

Journal Articles

Unique Pattern of Raf-1 Kinase Inhibitory Protein (RKIP) Expression in Multiple Myeloma (MM): RKIP Overexpression and RKIP Phosphorylation Is Common in MM Tumor Cells

Stavroula Baritaki, Ph.D., Sara Huerta-Yepez, Ph.D., Ma de Lourdes Cabera-Muñoz, MD, Clara Rivera-Pazos, MD, Kam Yeung, Ph.D., Manuel L Penichet, M.D., Ph.D., Haiming Chen, MD, PhD, James R. Berenson, MD, Benjamin Bonavida, PhD

Blood (2008) 112 (11): 2729.

https://doi.org/10.1182/blood.V112.11.2729.2729

Published: 2008

Journal Articles

The Novel Proteasome Inhibitor NPI-0052 Induces the Expression of Raf-1 Kinase Inhibitor Protein RKIP) in B-NHL via Inhibition of the Transcription Repressor Snail: Roles of Snail and RKIP in Sensitization to TRAIL Apoptosis

Stavroula Baritaki, Aaron Chapman, Katherine Wu, Kam Yeung, Ph.D., Demetrios Spandidos, Ph.D., James R. Berenson, MD, Michael A. Palladino, MS, PhD, Benjamin Bonavida, PhD

Blood (2008) 112 (11): 2611.

https://doi.org/10.1182/blood.V112.11.2611.2611

Published: 2008

Journal Articles

Expression, Role in Transformation and Prognostic Significance of the Transcription Factor Yin Yang 1 (YY1) in Non-Hodgkin’s Lymphoma: Analyses in NHL Tissues by Experimental and Bioinformatic Approaches

Massimo Libra, Giancarlo Castellano, Stavroula Baritaki, Sara Huerta-Yepez, Giovanni Ligresti, Loredana Militello, Grazia Malaponte, Franca Stivala, Silvana Canevari, Benjamin Bonavida, PhD

Blood (2008) 112 (11): 2827.

https://doi.org/10.1182/blood.V112.11.2827.2827

Published: 2008

Journal Articles

Prognostic Significance of Both the Cytoplasmic and Nuclear Overexpression of Yin-Yang 1 (YY1) among Patients with Multiple Myeloma (MM)

Sara Huerta-Yepez, Ph.D., Clara Rivera-Pazos, MD, Massimo Libra, Stavroula Baritaki, Haiming Chen, MD, PhD, James R. Berenson, MD, Benjamin Bonavida, PhD

Blood (2008) 112 (11): 2730.

https://doi.org/10.1182/blood.V112.11.2730.2730

Published: 2008

Journal Articles

Synergy in Apoptosis Is Achieved in B-NHL by the Combination of Rituximab and the Novel Proteasome Inhibitor NPI-0052: Pivotal Role of Induction of the Immune Surveillance Cancer Gene Product RKIP

Mario I. Vega, PhD, Melisa Martinez- Paniagua, Sara Huerta-Yepez, PhD., Eriko Suzuki, Kazuo Umezawa, Kam Yeung, Ph.D., Massimo Libra, Stavroula Baritaki, Michael A. Palladino, PhD, Benjamin Bonavida, PhD

Blood (2008) 112 (11): 4973.

https://doi.org/10.1182/blood.V112.11.4973.4973

Published: 2008

Journal Articles

Mechanism of Obatoclax (GX15-070; Bcl-2 Family Inhibitor)-Induced-Sensitization of B-NHL Cells to TRAIL-Mediated Apoptosis: Inhibition of the NF-κB Survival Pathway and the DR5 Transcription Repressor Yin Yang1 (YY1)

Melisa Martinez- Paniagua, Mario I. Vega, PhD, Sara Huerta-Yepez, PhD, Bonilla Gonzalez, PhD, Vanessa Suarez, Stavroula Baritaki, PhD, James R. Berenson, MD, Benjamin Bonavida, PhD

Blood (2008) 112 (11): 4976.

https://doi.org/10.1182/blood.V112.11.4976.4976

Published: 2008

Journal Articles

Galiximab (anti-CD80 mAb)-Induced Cell Triggering Results in the Inhibition of Constitutive NF-Kb Activity in Raji: Contrasting Roles of Snail and RKIP in the Regulation of Drug/Immune Resistance

Melisa Martinez-Paniagua, Mario I. Vega, PhD, Sara Huerta-Yepez, PhD., Stavroula Baritaki, James R. Berenson, MD, Haris Hariharan, Benjamin Bonavida, PhD

Blood (2008) 112 (11): 3623.

https://doi.org/10.1182/blood.V112.11.3623.3623

Published: 2008

Journal Articles

Identification of Differentially Expressed Genes in the Rituximab- Resistant Clone (Ramos RR1) Compared to Wildtype Sensitive Ramos: Therapeutic Implications in Rituximab-Resistance

Stavroula Baritaki, PhD, Jose Rodriguez, Gustavo Helguera, PhD, Melisa Martinez-Paniagua, Mario Vega, PhD, Sara Huerta-Yepez, PhD., Ali Jazirehi, PhD, Demetrios Spandidos, PhD, Manuel L Penichet, M.D., Ph.D., Benjamin Bonavida, PhD

Blood (2008) 112 (11): 3770.

https://doi.org/10.1182/blood.V112.11.3770.3770

Published: 2008

Journal Articles

Molecular Mechanism by Which Rituximab Sensitizes B-NHL Cells to TRAIL Apoptosis: Induction of RKIP and DR5 Expression Via Inhibition of NF-Kb, Snail, and YY1.

Mario I. Vega, PhD, Melisa Martinez-Paniagua, Sara Huerta-Yepez, PhD., Yeung Kam, Stavroula Baritaki, Benjamin Bonavida, PhD

Blood (2008) 112 (11): 1596.

https://doi.org/10.1182/blood.V112.11.1596.1596

Published: 2008

Journal Articles

Rituximab Sensitizes TRAIL-Resistant B-NHL Lines to Apoptosis by Both TRAIL and Fully Humanized Antibodies Targeting TRAIL-R1 (Mapatumumab) and TRAIL-R2 (Lexatumumab).

Mario I. Vega, PhD, Sara Huerta-Yepez, PhD, Stavroula Baritaki, PhD, Melisa A. Martinez-Paniagua, McS, Cesar R. Gonzalez-Bonilla, MD, PhD, Benjamin Bonavida, PhD

Blood (2007) 110 (11): 2350.

https://doi.org/10.1182/blood.V110.11.2350.2350

Published: 2007

NARROW

Regulation of Drug Resistance Via the Overexpression of Phopho-RKIP (P-RKIP) in Multiple Myeloma: Dephosphorylation of P-RKIP Reverses Drug Resistance

High Expression of the Resistant Factor YY1 and Low Expression of the RKIP Chemosensitizing Factor in Multiple Myeloma: Delineation of Several Crosstalk Pathways That Regulate the Expression of These Factors

Targeting the Over-Expressed Transcription Factor Yin-Yang 1 (YY1) Sensitizes Resistant Multiple Myeloma (MM) Cell Lines to Apoptosis by Bortezomib or Melphalan,

The Overexpression of Inactive Phosphorylated Raf-1 Kinase Inhibitory Protein (RKIP) in Multiple Myeloma (MM) Regulates the Resistance to Bortezomib-Induced Cytotoxicity: Reversal of Resistance by the PKC Inhibitor Bisindolylmalemide

Rituximab Inhibits the PI3K/Akt Survival Pathway In B-NHL Cells Via Induction of the PTEN Tumor Suppressor: Pivotal Roles of the Inhibition of the PTEN Repressors Snail and YY1

An ADCC-Independent Mechanism of Rituximab-Mediated B-NHL Cells Depletion Via Sensitization to Cell Death through the Expression of TRAIL on NK Cells

Reversal of Drug/TRAIL-Resistant B-NHL Cells to Apoptosis by the Combination of Rituximab (anti-CD20) and Either Mapatumumab or Lexatumumab

Photodynamic Therapy (PDT)-Mediated Inhibition of the Transcription Factor Yin Yang 1 (YY1) That Regulates Resistance In Lymphoma

Inhibition of the RKIP and PTEN-Transcription Repressor Snail in B-NHL by the Proteasome Inhibitor NPI-0052: Roles of RKIP and PTEN Induction in the Reversal of Resistance to TRAIL Apoptosis.

The Anti-CD 20 Mab R603 Induces PTEN and RKIP Expression in B-NHL Cells: Role in Inhibition of Constitutively Activated Akt and NF-ΚB Survival Anti-Apoptotic Pathways.

Unique Pattern of Raf-1 Kinase Inhibitory Protein (RKIP) Expression in Multiple Myeloma (MM): RKIP Overexpression and RKIP Phosphorylation Is Common in MM Tumor Cells

The Novel Proteasome Inhibitor NPI-0052 Induces the Expression of Raf-1 Kinase Inhibitor Protein RKIP) in B-NHL via Inhibition of the Transcription Repressor Snail: Roles of Snail and RKIP in Sensitization to TRAIL Apoptosis

Expression, Role in Transformation and Prognostic Significance of the Transcription Factor Yin Yang 1 (YY1) in Non-Hodgkin’s Lymphoma: Analyses in NHL Tissues by Experimental and Bioinformatic Approaches

Prognostic Significance of Both the Cytoplasmic and Nuclear Overexpression of Yin-Yang 1 (YY1) among Patients with Multiple Myeloma (MM)

Synergy in Apoptosis Is Achieved in B-NHL by the Combination of Rituximab and the Novel Proteasome Inhibitor NPI-0052: Pivotal Role of Induction of the Immune Surveillance Cancer Gene Product RKIP

Mechanism of Obatoclax (GX15-070; Bcl-2 Family Inhibitor)-Induced-Sensitization of B-NHL Cells to TRAIL-Mediated Apoptosis: Inhibition of the NF-κB Survival Pathway and the DR5 Transcription Repressor Yin Yang1 (YY1)

Galiximab (anti-CD80 mAb)-Induced Cell Triggering Results in the Inhibition of Constitutive NF-Kb Activity in Raji: Contrasting Roles of Snail and RKIP in the Regulation of Drug/Immune Resistance

Identification of Differentially Expressed Genes in the Rituximab- Resistant Clone (Ramos RR1) Compared to Wildtype Sensitive Ramos: Therapeutic Implications in Rituximab-Resistance

Molecular Mechanism by Which Rituximab Sensitizes B-NHL Cells to TRAIL Apoptosis: Induction of RKIP and DR5 Expression Via Inhibition of NF-Kb, Snail, and YY1.

Rituximab Sensitizes TRAIL-Resistant B-NHL Lines to Apoptosis by Both TRAIL and Fully Humanized Antibodies Targeting TRAIL-R1 (Mapatumumab) and TRAIL-R2 (Lexatumumab).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only